ABCB1 and breast cancer: A study by BC Gomes et al. showed that the expression of miR‐548 K in doxorubicin‐resistant cancer cells increased after 16 weeks of doxorubicin resistance withdrawal; however, the expression of ABCB1 protein diminished.